Task order 7 - DOK7
Ended Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
A&G Pharmaceutical, Inc. UEI SN6SWFABJXL1
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $105,670
Award facts
- Contract value 100% obligated
- $105,669.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $105,669.50 firm fixed price delivery order to A&G Pharmaceutical, Inc., doing business as Precision Antibody, for Task Order 7 under the DOK7 contract vehicle. Precision Antibody will provide custom antibody development services in support of biomedical research at the Center's location in Potomac, Maryland by the stated completion date of March 17, 2025. As a global leader in these services across research, diagnostic, and therapeutic applications, Precision Antibody has extensive experience supporting the Department of Health and Human Services and its components through similar contracts, including the National Institutes of Health organizations focused on areas such as Alzheimer's disease, malaria, COVID-19, oncology, and drug development. This delivery order was not designated with a set-aside and represents the seventh task issued against the DOK7 contract to advance the National Center's translational sciences mission.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to A&G Pharmaceutical, Inc. by National Institute on Drug Abuse (National Institutes of Health) on March 18, 2024.
How much is contract 75N95024F00001 worth?
The government has obligated $105,670 on 75N95024F00001.
Which agency awarded contract 75N95024F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a delivery order under 75N95018D00010, an indefinite delivery contract.
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award